Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Assets Average (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Assets Average for 15 consecutive years, with $162.8 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 29.87% to $162.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $162.8 million through Dec 2025, up 29.87% year-over-year, with the annual reading at $145.8 million for FY2025, 20.5% up from the prior year.
  • Assets Average for Q4 2025 was $162.8 million at Gyre Therapeutics, up from $156.0 million in the prior quarter.
  • The five-year high for Assets Average was $162.8 million in Q4 2025, with the low at $11.2 million in Q3 2023.
  • Average Assets Average over 5 years is $90.9 million, with a median of $98.6 million recorded in 2021.
  • The sharpest move saw Assets Average crashed 80.45% in 2023, then skyrocketed 1001.03% in 2024.
  • Over 5 years, Assets Average stood at $67.1 million in 2021, then dropped by 13.73% to $57.9 million in 2022, then rose by 9.27% to $63.3 million in 2023, then surged by 98.13% to $125.3 million in 2024, then increased by 29.87% to $162.8 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $162.8 million, $156.0 million, and $141.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.